IP for Scientists

Universities Allied for Essential Medicines (UAEM)

UC Berkeley

Agenda

• Patent law fundamentals• Patenting @ Berkeley• Office of Intellectual

Property & Industry Research Alliances (IPIRA)

• University patenting and global health

• Who we are – UAEM

What is Intellectual Property?

• Intellectual Property (IP): person’s right to have control over the things s/he creates.

• Examples of types of IP

Patent Copyright Trademark

The Balance of IP Law

IP is an attempt to balance between providing financial incentive for innovation and allowing for access to technologies

Access• Allow the public to

use and benefit from the invention

Ownership• Promote research

and protect investments

• Create competition

Patent Law – Give and Take

What you give• A written description of

your invention

• Enablement: disclose how to make and use your invention

• Best mode: disclose the best mode of patenting your invention

What you get• An exclusive right to

exclude others from making, selling, or using your invention for a limited period of time

• The power to assign or license your rights to someone else

What do universities do with patents?

• Licensing: letting a third party use the patented technology under certain conditions– Exclusive license

– Non-exclusive license

Licensor

Licensee

Research Decision to Patent License to Industry

Patenting @ Berkeley

• Office of Intellectual Property & Industry Research Alliances (IPIRA)

• Assistant Vice Chancellor Carol Mimura, Ph.D.

• [Picture of building]

Office of Intellectual Property & Industry Research Alliances (IPIRA)

Office of Technology Licensing (OTL)

Industry Alliances Office (IAO)

• One stop shop for industry-university relations, including sponsored research and intellectual property.

(Assistant Vice Chancellor Carol Mimura )

Contact IPIRA for…

• Disclose an invention

• Material transfer

• Sponsored research agreement

http://otl.berkeley.edu

University Licensing & Global Health: Why Should We Care?

• Gaps in Drug Development Pipeline– Lack of research– Lack of production

• Poor access– High, unaffordable

prices– Lack of adaptive formulations for drugs

• Why? Business profit-based incentives

• Result: Lack of access to life-saving drugs

What can universities do?

• Universities are major players in the drug development field – 40-50% of pharmaceutical industry’s new products rely on academic research.

What can Berkeley do?

• Berkeley - a history of public service– "The distinctive mission of the University is to serve

society as a center of higher learning, providing long-term societal benefits through transmitting advanced knowledge, discovering new knowledge, and functioning as an active working repository of organized knowledge.”

• Socially responsible licensing

Socially Responsible Licensing

• Maximize the social benefit of discoveries made at Berkeley through equitable licensing

• Example policies– Royalty-free license terms for

products sold in developing world– Requirement that licensees provide

low-cost therapies for free or for minimal profit in developing world

– Private-public partnerships

(Peg Skorpinski photo)

Universities Allied forEssential Medicines

• International student organization

• Two-fold Mission– Ensuring access to

life-saving medicines– Promoting research

on neglected diseases• www.essentialmedicine.org• http://uaem.berkeley.edu